Abstract
The present study was carried out to elucidate the distribution of calcium-independent phospholipase A2 (iPLA2) in the normal monkey brain. iPLA2 immunoreactivity was observed in structures derived from the telencephalon, including the cerebral neocortex, amygdala, hippocampus, caudate nucleus, putamen, and nucleus accumbens, whereas structures derived from the diencephalon, including the thalamus, hypothalamus and globus pallidus were lightly labeled. The midbrain, vestibular, trigeminal and inferior olivary nuclei, and the cerebellar cortex were densely labeled. Immunoreactivity was observed on the nuclear envelope of neurons, and dendrites and axon terminals at electron microscopy. Western blot analysis showed higher levels of iPLA2 protein in the cytosolic, than the nuclear fraction, but little or no protein in the membrane fraction. Similarly, subcellular fractionation studies of iPLA2 activity in rat brain cortical cell cultures showed greater enzymatic activity in the cytosolic, than the nuclear fraction, and the least activity in non-nuclear membranes. The association of iPLA2 with the nuclear envelope suggests a role of the enzyme in nuclear signaling, such as during neuronal proliferation and differentiation or death. In addition, the localization of iPLA2 in dendrites and axon terminals suggests a role of the enzyme in neuronal signaling.
Similar content being viewed by others
References
ANTONY, P., FREYSZ, L., HORROCKS, L. A. & FAROOQUI, A. A. (2001) Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochemical Research 26, 83–88.
ANTONY, P., FREYSZ, L., HORROCKS, L. A. & FAROOQUI, A. A. (2003) Ca2+-independent phospholipases A2 and production of arachidonic acid in nuclei of LA-N-1 cell cultures: A specific receptor activation mediated with retinoic acid. Brain Research Molecular Brain Research 115, 187–95.
BRADFORD, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248–254.
CLARK, J. D., SCHIEVELLA, A. R., NALEFSKI, E. A. & LIN, L. L. (1995) Cytosolic phospholipase A2. Journal of Lipid Mediators and Cell Signaling 12, 83–117.
FAROOQUI, A. A., ANTONY, P., ONG, W. Y., HORROCKS, L. A. & FREYSZ, L. (2004) Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Research Reviews 45, 179–195.
FAROOQUI, A. A. & HORROCKS, L. A. (2004) Brain phospholipases A2: A perspective on the history. Prostaglandins, Leukotrienes and Essential Fatty Acids 71, 161–169.
FAROOQUI, A. A., HORROCKS, L. A. & FAROOQUI, T. (2000a) Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chemistry and Physics of Lipids 106, 1–29.
FAROOQUI, A. A., HORROCKS, L. A. & FAROOQUI, T. (2000b) Deacylation and reacylation of neural membrane glycerophospholipids: A matter of life and death. Journal of Molecular Neuroscience 14, 123–135.
FAROOQUI, A. A., YANG, H. C., ROSENBERGER, T. A. & HORROCKS, L. A. (1997) Phospholipase A2 and its role in brain tissue. Journal of Neurochemistry 69, 889–901.
FAROOQUI, A. A. & HORROCKS, L. A. (2005) Signaling and interplay among PLA2, PLC, and PLD of LA-N-1 cell nuclei. Reproduction, Nutrition and Development 45:613–631.
FORLENZA, O. V., SCHAEFFER, E. I. & GATTAZ, W. F. (2002) Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons. Journal of Neural Transmission 109, 623–631.
FUJITA, S., IKEGAYA, Y., NISHIKAWA, M., NISHIYAMA, N. & MATSUKI, N. (2001) Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices. British Journal of Pharmacology 132, 1417–1422.
FUJITA, S., IKEGAYA, Y., NISHIYAMA, N. & MATSUKI, N. (2000) Ca2+-independent phospholipase A2 inhibitor impairs spatial memory of mice. The Japanese Journal of Pharmacology 83, 277–278.
HORROBIN, D. F. (2003) Phospholipid and fatty acid biochemistry in schizophrenia. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D. F.), pp 123–162, Marius Press, Lancashire, U.K.
LARSSON, P.K., CLAESSON, H.E., & KENNEDY, B.P. (1998) Multiple splice variants of the human calcium-independent phospholipase A2and their effect on enzyme activity. Journal of Biological Chemistry 273, 207–214.
LEDEEN, R.W. & WU, G. (2004) Nuclear lipids: Key signaling effectors in the nervous system and other tissues. Journal of Lipid Research 45, 1–8.
MA, Z., WANG, X., NOWATZKE, W., RAMANADHAM, S. & TURK, J. (1999) Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1. Journal of Biological Chemistry 274, 9607–9616.
MARTELLI, A. M., FALA, F., FAENZA, I., BILLI, A. M., CAPPELLINI, A., MANZOLI, L. & COCCO, L. (2004) Metabolism and signaling activities of nuclear lipids. Cellular and Molecular Life Sciences 61, 1143–1156.
MASSICOTTE, G. (2000) Modification of glutamate receptors by phospholipase A2: Its role in adaptive neural plasticity. Cellular and Molecular Life Sciences 57, 1542–1550.
MURAKAMI, K. & ROUTTENBERG, A. (2003) The role of fatty acids in synaptic growth and plasticity. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D. F.), pp. 77–92. Marius Press, Lancashire, U.K.
NOMURA, T., NISHIZAKI, T., ENOMOTO, T. & ITOH, H. (2001) A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A2 signaling pathway. Life Sciences 68, 2885–2891.
ONG, W. Y., HORROCKS, L. A. & FAROOQUI, A. A. (1999a) Immunocytochemical localization of cPLA2 in rat and monkey spinal cord. Journal of Molecular Neuroscience 12, 123–130.
ONG, W. Y., SANDHYA, T. L., HORROCKS, L. A. & FAROOQUI, A. A. (1999b) Distribution of cytoplasmic phospholipase A2 in the normal rat brain. Journal fü r Hirnforschung 39, 391–400.
RORDORF, G., KOROSHETZ, W. J. & BONVENTRE, J. V. (1991) Heat shock protects cultured neurons from glutamate toxicity. Neuron 7, 1043–1051.
ROSS, B. M. (2003) Phospholipase A2-associated processes in the human brain and their role in neuropathology and psychopathology. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D.F.), pp. 163–182. Marius Press, Lancashire, U.K.
ROSS, B. M., HUDSON, C., ERLICH, J., WARSH, J. J. & KISH, S. J. (1997) Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry 54, 487–494.
ROSS, B. M., TURENNE, S., MOSZCZYNSKA, A., WARSH, J. J. & KISH, S. J. (1999) Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research 821, 407–413.
SHINZAWA, K. & TSUJIMOTO, Y. (2003) PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. The Journal of Cell Biology 163, 1219–1230.
SHIRAI, Y. & ITO, M. (2004) Specific differential expression of phospholipase A2 subtypes in rat cerebellum. Journal of Neurocytology 33, 297–307.
SMESNY, S., KINDER, D., WILLHARDT, I., ROSBURG, T., LASCH, J., BERGER, G. & SAUER, H. (2005) Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia. Biological Psychiatry 57, 399–405.
ST-GELAIS, F., MENARD, C., CONGAR, P., TRUDEAU, L. E. & MASSICOTTE, G. (2004) Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus 14, 319–325.
TAMIYA-KOIZUMI, K. (2002) Nuclear lipid metabolism and signaling. Journal of Biochemistry 132, 13–22.
WOLF, M. J., IZUMI, Y., ZORUMSKI, C. F. & GROSS, R. W. (1995) Long-term potentiation requires activation of calcium-independent phospholipase A2. Federation of European Biochemical Societies Letters 377, 358–362.
YANG, H. C., MOSIOR, M., JOHNSON, C. A., CHEN, Y. & DENNIS, E. A. (1999a) Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Analytical Biochemistry 269, 278–288.
YANG, H. C., MOSIOR, M., NI, B. & DENNIS, E. A. (1999b) Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2from rat brain. Journal of Neurochemistry 73, 1278–1287.
YEO, J. F., ONG, W. Y., LING, S. F. & FAROOQUI, A. A. (2004) Intracerebroventricular injection of phospholipases A2inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112, 148–155.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ong, WY., Yeo, JF., Ling, SF. et al. Distribution of calcium-independent phospholipase A2 (iPLA2) in monkey brain. J Neurocytol 34, 447–458 (2005). https://doi.org/10.1007/s11068-006-8730-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11068-006-8730-4